No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm

医学 射频消融术 肝细胞癌 切除术 内科学 烧蚀 胃肠病学 放射科 外科
作者
Kayvan Mohkam,P.-N. Dumont,Anne‐Frédérique Manichon,Jean-Christophe Jouvet,Loïc Boussel,Philippe Merle,Christian Ducerf,Mickaël Lesurtel,Agnès Rode,Jean‐Yves Mabrut
出处
期刊:Journal of Hepatology [Elsevier]
卷期号:68 (6): 1172-1180 被引量:87
标识
DOI:10.1016/j.jhep.2018.01.014
摘要

Background & Aims

No-touch multibipolar radiofrequency ablation (NTM-RFA) represents a novel therapy that surpasses standard RFA for hepatocellular carcinoma (HCC), but it has not been compared to surgical resection (SR). We aimed to compare the outcomes of NTM-RFA and SR for intermediate-sized HCC.

Methods

Between 2012 and 2016, 141 patients with solitary HCC ranging from 2 to 5 cm were treated by NTM-RFA or SR at a single-center. The outcomes of 128 patients were compared after using inverse probability of treatment weighting (IPTW).

Results

Seventy-nine patients had NTM-RFA and 62 had SR. After IPTW, the two groups were well-balanced for most baseline characteristics including tumor size, location, etiology, severity of underlying liver disease and alpha-fetoprotein level. Morbidity was higher (67.9% vs. 50.0%, p = 0.042) and hospital stay was longer (12 [IQR 8–13] vs. 7 [IQR 5–9] days, p <0.001) after SR. Local recurrence rates at one and three years were 5.5% and 10.0% after NTM-RFA and 1.9% and 1.9% after SR, respectively (p = 0.065). The rates of systematized recurrence (within the treated segment or in an adjacent segment within a 2 cm distance from treatment site) were higher after NTM-RFA (7.4% vs. 1.9% at one year, 27.8% vs. 3.3% at three years, p = 0.008). Most patients with recurrence were eligible for rescue treatment, resulting in similar overall survival (86.7% after NTM-RFA, 91.4% after SR at three years, p = 0.954) and disease-free survival (40.8% after NTM-RFA, 56.4% after SR at three years, p = 0.119).

Conclusion

Compared to SR, NTM-RFA for solitary intermediate-sized HCC was associated with less morbidity and more systematized recurrence, while the rate of local recurrence was not significantly different. Most patients with intrahepatic recurrence remained eligible for rescue therapies, resulting in equivalent long-term oncological results after both treatments.

Lay summary

Outcomes of patients treated for intermediate-sized hepatocellular carcinoma by surgical resection or no-touch multibipolar radiofrequency ablation were compared. No-touch multibipolar radiofrequency ablation was associated with a lower overall morbidity and a higher rate of systematized recurrence within the treated segment or in an adjacent segment within a 2 cm distance from the initial tumor site. Most patients with intrahepatic recurrence remained eligible for rescue curative therapy, enabling them to achieve similar long-term oncological results after both treatments.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
方梓言发布了新的文献求助10
2秒前
量子星尘发布了新的文献求助10
3秒前
Ray发布了新的文献求助10
3秒前
4秒前
4秒前
shego发布了新的文献求助10
4秒前
momo发布了新的文献求助10
5秒前
丘比特应助fann采纳,获得10
7秒前
7秒前
丰富的刺猬完成签到 ,获得积分10
9秒前
9秒前
9秒前
10秒前
yuanjun完成签到,获得积分20
11秒前
慕青应助jia采纳,获得20
11秒前
12秒前
彭于晏应助lingxu采纳,获得10
12秒前
小透明发布了新的文献求助10
12秒前
13秒前
13秒前
14秒前
15秒前
独特涵柏发布了新的文献求助10
15秒前
鲤角兽完成签到,获得积分10
16秒前
诸沧海发布了新的文献求助10
16秒前
量子星尘发布了新的文献求助10
17秒前
errui完成签到,获得积分10
18秒前
何海发布了新的文献求助10
18秒前
18秒前
19秒前
无极微光应助健壮平灵采纳,获得20
19秒前
20秒前
22秒前
华仔应助白泽采纳,获得10
22秒前
1nooooo完成签到 ,获得积分10
22秒前
22秒前
心灵尔安完成签到,获得积分10
22秒前
科研通AI2S应助jmy1995采纳,获得10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5713133
求助须知:如何正确求助?哪些是违规求助? 5213704
关于积分的说明 15269646
捐赠科研通 4864955
什么是DOI,文献DOI怎么找? 2611759
邀请新用户注册赠送积分活动 1562014
关于科研通互助平台的介绍 1519213